What s New in Adolescent Contraception?
|
|
- Maude Cole
- 6 years ago
- Views:
Transcription
1 What s New in Adolescent Contraception? Abby Furukawa, MD Legacy Medical Group Portland Obstetrics and Gynecology April 29, 2017
2 Objectives Provide an update on contraception options for the adolescent female Discuss LARC methods and dispel common myths Review other contraceptive options Select an COCP and troubleshooting side effects 5/2/2017 LEGACY HEALTH 2
3 Financial Relationships I, Dr. Abby Furukawa, have no relationship to any aspect of private industry
4 Pediatricians and Adolescent Sexual Health Already a trusted source of information for both patient and her guardians Able to assess for STD risk, screen for pregnancy, help young women and their families make healthy choices May be first point of information regarding contraception options May 2, 2017 LEGACY HEALTH 4
5 LARC = Long Acting Reversible Contraception LEGACY HEALTH 5
6 Contraceptive CHOICE Project May 2, 2017 LEGACY HEALTH 6
7 LARC Advantages Highly efficacious Easy to use and forgettable Alternative to permanent sterilization methods Safe for most women (even teens and nullips) Long acting but rapidly reversible Private and doesn t interfere with intercourse spontaneity Cost effective if planned use >1 year Few contraindications Non-contraceptive benefits May 2, 2017 LEGACY HEALTH 7
8 Levonorgestrel IUD 52mg device 52mg Levonorgestrel device, releases 18-20mcg/day Lasts up to 5-7 years 1 st year pregnancy rate 0.1% Significant reduction in menstrual bleeding (20% amenorrhea after 1 st year, 40-50% after 2 nd year) Non-contraceptive benefits (anemia, dysmenorrhea, heavy bleeding, endometriosis) Side effects: prolonged bleeding, persistent spotting, irregular bleeding May 2, 2017 LEGACY HEALTH 8
9 Levonorgestrel IUD 13.5mg device 13.5mg Levonorgestrel device releasing 14 mcg/day Lasts up to 3 years 3 year cumulative pregnancy rate 0.9% Some reduction in menstrual bleeding (6% amenorrhea at 1 st year, 12% at 2 nd year) Side effects: irregular bleeding No non-contraceptive benefits known May 2, 2017 LEGACY HEALTH 9
10 Copper (TCu380A) IUD Lasts up to 10 years 1 st year pregnancy rate % Most effective form of Emergency Contraception (and only IUD form) Completely non-hormonal Side effects heavier, longer, more painful cycles for some women (but doesn t increase discontinuation rates) May 2, 2017 LEGACY HEALTH 10
11 IUD Contraindications Distorted uterine cavity (bicornuate uterus, fibroids distorting cavity, extremely large or small cavity) Active pelvic infection (PID or after septic abortion) Known or suspected pregnancy Wilson s disease/cu allergy (Copper IUD) Current breast cancer, active liver disease May 2, 2017 LEGACY HEALTH 11
12 IUD Complications Expulsion (2-5%) Perforation (1/1000) Intrauterine infection Irregular/abnormal bleeding Ectopic pregnancy Luteal phase pregnancy May 2, 2017 LEGACY HEALTH 12
13 IUD Myth #1: IUDs cause Infertility Infertility no more likely after discontinuation of IUDs than other reversible methods Large case-control study looking at causes of tubal infertility showed that the presence of chlamydial antibodies, not prior IUD use was associated with infertility Baseline fertility returns rapidly after IUD removal May 2, 2017 LEGACY HEALTH 13
14 IUD Myth #2: IUDs are Not Safe to Place in Teens or Nulliparous Women Placement is not technically more difficult in teens compared to older women Discomfort from placement is common, but anticipatory guidance and analgesia during procedure is helpful No definitive superior method for lessened discomfort, but NSAIDs, paracervical blocks, anxiolytics, misoprostol are widely used May 2, 2017 LEGACY HEALTH 14
15 IUD Myths #3: IUDs cause infections Relative risk of pelvic inflammatory disease (PID) is increased only in the first 20 days after insertion, then returns to baseline Same day chlamydia/gonorrhea screening for teens/at risk populations recommended, can be treated with IUD in place Some evidence that LNG-IUDs actually lower risk of PID secondary to thickened cervical mucous May 2, 2017 LEGACY HEALTH 15
16 IUD Myths #4: IUDs cause Ectopic pregnancy Women using NO contraception have a 10-fold higher risk of ectopic because their chance of pregnancy is higher Should pregnancy occur with IUD in place, however, ectopic risk is 30% May 2, 2017 LEGACY HEALTH 16
17 Etonogestrel Implant 68mg etonogestrel releasing 70 > 25 mcg/day Lasts up to 3 years Radio-opaque 3 year cumulative pregnancy rate 0.38% Side effects: unpredictable bleeding (33% infrequent bleeding, 20% prolonged, 20% amenorrhea) Non-contraceptive benefits reduced dysmenorrhea, pelvic pain, anemia 5/2/2017 LEGACY HEALTH 17
18 Depot Medroxyprogesterone Acetate (DMPA) DMPA 150mg/1mL IM every 3 months (13w) Inhibits ovulation 0.7% 3 year failure rate Bleeding pattern: > 1 st 3 months irregular bleeding is common > Nearly 50% amenorrhea by 1 year>75% with prolonged use Other side effects: headaches, mood changes, weight changes Non-contraceptive benefits reduced dysmenorrhea, pelvic pain, anemia, hygiene easier, endometrial protection, lack of drug interactions Delay in return to fertility 5/2/2017 LEGACY HEALTH 18
19 DMPA and Bone Density 2004 FDA Black Box warning 2005 WHO Technical Consult > No restrictions on use (18-45yo) or time period of use > Teens: advantages generally outweigh safety concerns Current evidence suggests that losses are substantially or fully reversible Unclear whether DMPA affects fracture risk later in life Concerns about BMD effects should not reduce use past 2 year mark Consider alternative methods (LARC) if long-term use is planned, particularly in women with other risk factors for BMD loss Routine DEXA screening is not recommended for DMPA users 5/2/2017 LEGACY HEALTH 19
20 Combination Oral Contraceptive Pills Estrogen + Progestin > E2: Ethinyl estradiol, estradiol valerate > P4: Norethindrone, Levonorgestrel, Desogestrel, Drospirenone Monophasic vs multiphasic Continuous vs cyclic 92% typical use effectiveness Non-contraceptive benefits > Dysmenorrhea, menorrhagia, cycle regulation, anemia > Reduced hair growth, acne > May have benefits for moods, menstrual migraines > Reduced risk of endometrial, ovarian, and colorectal cancers 5/2/2017 LEGACY HEALTH 20
21 Contraceptive Patch and Ring 5/2/2017 LEGACY HEALTH 21
22 How do I select a COCP for my patient? 1. Offer LARC method 2. Rule out contraindications > Smoker > 35 yo > Prior DVT/VTE, hereditary thrombophilia > Active hepatobiliary disease, severe inflammatory bowel disease, SLE > Migraine with focal neurologic symptoms 3. Is there an OCP that worked well for her in the past? 4. Periods or no periods? > Regular cycles vs breakthrough bleeding > Personal preference 5. Painful or heavy periods? > Pick something with short placebo or no placebo 6. Trouble remembering the pill? > Consider contraceptive ring or LARC method 5/2/2017 LEGACY HEALTH 22
23 How do I manage Breakthrough Bleeding? 30% of women will have this during the 1 st 3 months of use counsel them! Most common reason for spotting: forgetting pills Options: > Continue daily use, it ll sort itself out > Stop pill or ring x 3 days, then restart Consider switching to ring (more continuous application of hormone) Consider switching to a cyclic regimen (21-day or 24-day rather than 28) Norethindrone containing pills seem to be less likely to cause BTB 5/2/2017 LEGACY HEALTH 23
24 January 1, 2016 Year-long OCP Prescriptions! 5/2/2017 LEGACY HEALTH 24
25 VTE and Drospirenone Containing COCs Biological plausibility Overall risk of VTE in all OCP users is 3-9/10,000 woman-years compared to non-users (1-5/10,000 woman-years) Risk of VTE in drosperinone containing OCP users: 10.22/10,000 Risk of VTE during pregnancy: 20/10,000 Risk of VTE during 12 weeks postpartum: 40-65/10,000 5/2/2017 LEGACY HEALTH 25
26 Progestin Only Pills Option for women with contraindications to estrogen use Only 90% effective in women with normal fertility > Greater efficacy in women >40yo or lactating women Must be taken within 3 hour range every day Partial suppression of ovulation, but majority of efficacy from thickening cervical mucous Cycle regulation unlikely, many women will have irregular periods with this method 5/2/2017 LEGACY HEALTH 26
27 Selected References Ott, Mary, Sucato G, and Committee on Adolescence. Contraception for Adolescents. Pediatrics 2014; 134; e1257, October 2014 Long-acting reversible contraception: implants and intrauterine devices. Practice bulletin No American College of Obstetricians and Gynecologists. Obstetr Gynecol 2011;118: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices. Committee Opinion 539. ACOG, October 2012 Winner B, et al. Effectiveness of Long-Acting Reversible Contraception. N Engl J Med 2012;366: Secura G, et al. Provision of No-Cost, Long-Acting Contraception and Teenage Pregnancy. N Engl J Med 2014;371: Depo Medroxyprogesterone Acetate and Bone Effects. Committee Opinion 602. ACOG, June 2014 Risk of Venous Thromboembolism Among Users of Drospirenone-Containing Oral Contraceptive Pills. ACOG Committee Opinion 540. ACOG, November 2012 May 2, 2017 LEGACY HEALTH 27
28 Thank you!
29 Teens and Confidentiality in Oregon All minors may consent for any/all contraceptive services 5/2/2017 LEGACY HEALTH 29
30 Quick Start Method RHEDI/The Center for Reproductive Health Education In Family Medicine, Montefiore Medical Center, New York City. Copyright 2007 RHEDI. 5/2/2017 LEGACY HEALTH 30
LEARNING OBJECTIVES. Beyond the Pill: Long Acting Contraception. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy is Common
4:15 5 pm Beyond the Pill: Long Acting Contraceptives and IUDs Presenter Disclosure Information The following relationships exist related to this presentation: Christine L. Curry, MD, PhD: No financial
More informationUnintended Pregnancy is Common LEARNING OBJECTIVES. Distribution Of Contraception Use By Women In The Us. Unintended Pregnancy And Contraceptive Use
3:45 4:30 pm Beyond the Pill: Long Acting Contraceptives and IUDs Presenter Disclosure Information The following relationships exist related to this presentation: Christine L. Curry, MD, PhD: No financial
More informationContraception: Common Problems Faced in Office Practice. Jane S. Sillman, MD Brigham and Women s Hospital
Contraception: Common Problems Faced in Office Practice Jane S. Sillman, MD Brigham and Women s Hospital Disclosures I have no conflicts of interest Contraception: Common Problems How to discuss contraception
More informationInstruction for the patient
WS 4 Case 3 STI and IUD Your situation Instruction for the patient You are 32 years old, divorced and have one child; you have just started a new relationship You underwent surgical resection of the left
More informationContraception Choices: An Evidence Based Approach Case Study Approach. Susan Hellier PhD, DNP, FNP-BC, CNE
Contraception Choices: An Evidence Based Approach Case Study Approach Susan Hellier PhD, DNP, FNP-BC, CNE Objectives Describe the U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 (U.S. MEC)
More informationContraception and gynecological pathologies
1 Contraception and gynecological pathologies 18 years old, 2 CMI normal First menstruation at 14 years old Irregular (every 2/3 months), painful + She does not need contraception She is worried about
More informationLONG-ACTING REVERSIBLE CONTRACEPTION. Summary Tables
LONG-ACTING REVERSIBLE CONTRACEPTION Summary Tables Bridging the Divide: A Project of the Jacobs Institute of Women s Health June 2016 Table 1. Summary of LARC Methods Available Years Since Effective Copper
More informationContraception. Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine
Contraception Yolanda Evans MD MPH Assistant Professor of Pediatrics Division of Adolescent Medicine Disclosures No financial relationships to disclose I have no commercial, financial, research ties to
More informationContraception for Adolescents: What s New?
Contraception for Adolescents: What s New? US Medical Eligibility Criteria for Contraceptive Use Kathryn M. Curtis, PhD Division of Reproductive Health, CDC Expanding Our Experience and Expertise: Implementing
More informationTime Topic Speaker Abbreviation
1. Programme Sunday, 4 th November 2018 Time Topic Speaker Abbreviation 08:00 Welcome, distribution materials 08:30 Overview of the Medical Eligibility Criteria (2015), and the Selected Practices Recommendations
More informationContraception. Objectives. Unintended Pregnancy. Unintended Pregnancy in the US. What s the Impact? 10/7/2014
Contraception Tami Allen, RNC OB, MHA Robin Petersen, RN, MSN Perinatal Clinical Nurse Specialist Objectives Discuss the impact of unintended pregnancy in the United States Discuss the risks and benefits
More informationLong Acting Reversible Contraception: First Line Care for Adolescents. David A. Levine, MD, FAAP Melissa Kottke, MD, MPH, FACOG
Long Acting Reversible Contraception: First Line Care for Adolescents David A. Levine, MD, FAAP Melissa Kottke, MD, MPH, FACOG Disclosures Melissa Kottke is a Nexplanon trainer for Merck Objectives Describe
More information2/4/2011. What is your specialty? A. Family practice B. Internal medicine and subs C. OB/GYN D. Peds E. Surgery and subs
Steve P. Buchanan D.O. FACOOG(Dist.) TOMA Mid Winter February 11, 2011 Dallas,TX Associate Professor OB/GYN UNTHSC/TCOM 1987- present Executive Vice President, American College of Osteopathic Obstetricians
More informationLARC: Disclosures. Long Acting Reversible Contraception. Objectives 10/23/2013. I have no relevant financial disclosures
LARC: Long Acting Reversible Contraception Disclosures I have no relevant financial disclosures Jennifer Kerns, MD, MPH Assistant Professor, UCSF Obstetrics, Gynecology and Reproductive Sciences San Francisco
More informationDisclosures. Learning Objectives 4/18/2017 ADOLESCENT CONTRACEPTION UPDATE APRIL 28, Nexplanon trainer for Merck
ADOLESCENT CONTRACEPTION UPDATE APRIL 28, 2017 Brandy Mitchell, MN, RN, ANP BC, WHNP BC University of Iowa Hospitals and Clinics Obstetrics and Gynecology Iowa Association of Nurse Practitioners Spring
More informationAn Overview of Long Acting Reversible Contraception Methods
An Overview of Long Acting Reversible Contraception Methods Unintended Pregnancy All pregnancies should be intended; that is, they should be consciously and clearly desired at the time of conception. -
More informationArdhanu Kusumanto Oktober Contraception methods for gyne cancer survivors
Ardhanu Kusumanto Oktober 2017 Contraception methods for gyne cancer survivors Background cancer treatment Care of gyn cancer survivor Promotion of sexual, cardiovascular, bone, and brain health management
More informationMedical Eligibility for Contraception Use
Medical Eligibility for Contraception Use DIVISION OF REPRODUCTIVE HEALTH CENTERS FOR DISEASE CONTROL AND PREVENTION 2016 US Medical Eligibility Criteria for Contraceptive Use (US MEC) Purpose To assist
More informationWendy Shen, MD, PhD Refresher Course for the Family Physician April 5, 2018 Coralville, Iowa
Wendy Shen, MD, PhD Refresher Course for the Family Physician April 5, 2018 Coralville, Iowa Objectives Distinguish the different types of IUDs Understand the mechanism of action and selection of candidates
More informationTable I. Examples of Hormone and Tapering Regimens
Table I. Examples of Hormone and Tapering Regimens Severe AUB Heavy bleeding (soaking through 2 maxi pads an hour, 2 hours in a row) History of heavy menses Hemodynamically un (tachycardia, hypotensive,
More informationLinda Gregg NP, Janet Isabell NP, Sue Montei NP Clinical Reviewers Reproductive Health Unit
Linda Gregg NP, Janet Isabell NP, Sue Montei NP Clinical Reviewers Reproductive Health Unit What We Plan To Do Describe the U.S. Medical Eligibility Criteria for Contraceptive Use, 2016 (U.S. MEC) Explain
More informationInstructions how to use the ESC teach the teachers course and self-learning tool
Instructions how to use the ESC teach the teachers course and self-learning tool Welcome to the ESC advanced learning tool To improve and facilitate knowledge and use of contraception, abortion, sexually
More informationInstructions how to use the ESC teach the teachers course and self-learning tool
Instructions how to use the ESC teach the teachers course and self-learning tool Welcome to the ESC advanced learning tool To improve and facilitate knowledge and use of contraception, abortion, sexually
More informationApplication for inclusion of levonorgestrel - releasing IUD for contraception in the WHO Model List of Essential Medicines
Application for inclusion of levonorgestrel - releasing IUD for contraception in the WHO Model List of Essential Medicines 1. Summary statement of the proposal for inclusion LNG-IUS is an effective contraceptive;
More informationThe number of women using long-acting reversible
Long-acting reversible contraception: Who, what, when, and how This review provides practical tips and dispels some common misconceptions about these devices, which have higher rates of patient satisfaction
More informationPeggy Piascik, PhD Associate Professor, Pharmacy Practice and Science
Peggy Piascik, PhD Associate Professor, Pharmacy Practice and Science Department, UK College of Pharmacy Describe extended cycle oral contraceptive characteristics including dosing regimen, indications,
More information1. Ortiz, M. E et al. Mechanisms of action of intrauterine devices. Obstet & Gynl Survey 1996; 51(12), 42S-51S.
1 2 1. Ortiz, M. E et al. Mechanisms of action of intrauterine devices. Obstet & Gynl Survey 1996; 51(12), 42S-51S. The contraceptive action of all IUDs is mainly in the uterine cavity. The major effect
More informationFDA-Approved Patient Labeling Patient Information Mirena (mur-ā-nah) (levonorgestrel-releasing intrauterine system)
FDA-Approved Patient Labeling Patient Information Mirena (mur-ā-nah) (levonorgestrel-releasing intrauterine system) Mirena does not protect against HIV infection (AIDS) and other sexually transmitted infections
More informationPicking the Perfect Pill How to Effectively Choose an Oral Contraceptive
Focus on CME at Queen s University Picking the Perfect Pill How to Effectively Choose an Oral Contraceptive By Susan Chamberlain, MD, FRCSC There are over 20 oral contraceptive (OC) preparations on the
More informationProduct Information. Confidence that lasts
Confidence that lasts What is Mirena? Inhibition of sperm motility and function inside the uterus and the fallopian tubes, preventing fertilization (Videla-Rivero et al. 1987). Section of system Levonorgestrel
More informationInternational Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:
Review Article ISSN: 2319 9563 International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage: www.ijrpns.com A REVIEW ON INTRAUTERINE DEVICES Boddu Venkata Komali* 1, M. Kalyani
More informationDr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre
Dr. Nancy Van Eyk Associate Professor, Dalhousie University Chief of Gynaecology, IWK Health Centre AUB Outline Terminology Classification/Etiology Assessment Treatment Referral to Gynaecology U c pt 4
More information2
1 2 3 1. Usinger KM et al. Intrauterine contraception continuation in adolescents and young women: a systematic review. J Pediatr Adolesc Gynecol 2016; 29: 659 67. 2. Kost K et al. Estimates of contraceptive
More information1. Ng M et a l. Global, regional, and national prevalence of overweight and obesity in children and adults during : A systematic analysis
1 2 3 1. Ng M et a l. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980 2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet
More informationFamily Planning and Infertility
Family Planning and Infertility Chapter 20 Objectives Discuss types of reversible contraception Natural methods Mechanical barrier methods Hormonal contraceptives Discuss types of permanent contraception
More informationSexual and Reproductive Health for Adolescents with Disabilities
Wednesday, 10:00 11:30, D1 Objective: Sexual and Reproductive Health for Adolescents with Disabilities Colleen Dodich, MD Colleen.dodich@med.wmich.edu Identify effective methods for the practical application
More informationBLEEDING PATTERNS AND CONTRACEPTIVE DISCONTINUATION FG MHLANGA MTN ANNUAL MEETING 20 MARCH 2018
BLEEDING PATTERNS AND CONTRACEPTIVE DISCONTINUATION FG MHLANGA MTN ANNUAL MEETING 20 MARCH 2018 Introduction Bleeding with contraception may lead to discontinuation and possible unintended pregnancy What
More informationWelcome to Mirena. The Mirena Handbook: A Personal Guide to Your New Mirena. mirena.com. Mirena is the #1 prescribed IUD * in the U.S.
Mirena is the #1 prescribed IUD * in the U.S. Welcome to Mirena The Mirena Handbook: A Personal Guide to Your New Mirena *Intrauterine Device Supported by 2015-2016 SHS data INDICATIONS FOR MIRENA Mirena
More informationDisclosures. Objectives. Case: Anna. Case: Carla. Case: Beth. Contraception (for the Family Physician) 5/22/2015. Valary Gass, MD.
Contraception (for the Family Physician) Disclosures None Valary Gass, MD For Family Medicine Update June 2015 Objectives Help a patient choose a contraceptive that fits her life Consider co-morbidities
More informationCURRENT HORMONAL CONTRACEPTION - LIMITATIONS
CURRENT HORMONAL CONTRACEPTION - LIMITATIONS Oral Contraceptives - Features MERITS Up to 99.9% efficacy if used correctly and consistently Reversible method rapid return of fertility Offer non-contraceptive
More informationContraceptive Updates and Recommendations
Contraceptive Updates and Recommendations Emily M. Godfrey, MD MPH Associate Professor, Departments of Family Medicine and Obstetrics and Gynecology, University of Washington, Seattle WA Guest Researcher,
More informationContraceptive Updates and Recommendations
Contraceptive Updates and Recommendations Emily M. Godfrey, MD MPH Associate Professor, Departments of Family Medicine and Obstetrics and Gynecology, University of Washington, Seattle WA Guest Researcher,
More informationContraception Effective Methods of Birth Control
Contraception Effective Methods of Birth Control Abstinence Means choosing NOT to have sex It is the ONLY method that is 100% effective It is your right to be in control of your body and say NO What are
More informationExpanding Access to Birth Control: Will Women Get the Care They Need?
Expanding Access to Birth Control: Will Women Get the Care They Need? Target Audience: Pharmacists ACPE#: 0202-0000-18-045-L01-P Activity Type: Application-based Target Audience: ACPE#: Activity Type:
More informationEffective Contraception Utilization. Sarah Laiosa, DO Family Physician Contract Medical Director, EOCCO
Effective Contraception Utilization Sarah Laiosa, DO Family Physician Contract Medical Director, EOCCO Disclosures Contract Medical Director, EOCCO Objectives Illustrate how to best address contraception
More informationDisclosures CONTRACEPTION COUNSELING IN MEDICALLY COMPLEX ADOLESCENTS. Aletha Akers, MD, MPH and Lyndsey Benson, MD, MS
CONTRACEPTION COUNSELING IN MEDICALLY COMPLEX ADOLESCENTS Aletha Akers, MD, MPH and Lyndsey Benson, MD, MS Disclosures Aletha Akers Society of Family Planning Templeton Foundation National Institutes of
More informationUpdate on Medical and Surgical Therapy Sara Jane Pieper, MD Chair, Gynecology Development Team
ABNORMAL UTERINE BLEEDING Update on Medical and Surgical Therapy Sara Jane Pieper, MD Chair, Gynecology Development Team Goals Review appropriate medical therapies for abnormal uterine bleeding Review
More informationCONTRACEPTION OLD FRIENDS, NEW TRENDS
CONTRACEPTION OLD FRIENDS, NEW TRENDS AAP RECOMMENDATIONS 2014 1. Council about and ensure access to all contraceptive methods safe and appropriate describing most effective first. PEDIATRICS 134 (4)
More informationThe Doctor Is In. Brent N Davidson MD Vice Chair Women s Health Henry Ford Health System Medical Director Family Planning MDCH
The Doctor Is In Brent N Davidson MD Vice Chair Women s Health Henry Ford Health System Medical Director Family Planning MDCH Contraception Resources from the CDC: 2016 U.S. Medical Eligibility Criteria
More informationTopics. Periods Menopause & HRT Contraception Vulva problems
Girls stuff Topics Periods Menopause & HRT Contraception Vulva problems Menorrhagia Excessive menstrual loss occurring with regular or irregular cycles Ovulatory Anovulatory Usual blood loss 30-40ml per
More informationVCHIP LARC Needs Assessment Survey
VCHIP LARC Needs Assessment Survey Demographics 1. How many have you been in practice (post-training)? Choose one of the following answers 0-5 6-10 11-15 16-20 21 or more 2. What are your professional
More informationClinical Challenges in Contraception. Disclosures. Objectives Pharmacists 4/3/2018
Clinical Challenges in Contraception Kathleen Besinque, PharmD Sarah McBane, PharmD Disclosures Kathleen Besinque has nothing to disclose Sarah McBane has nothing to disclose Objectives Pharmacists Compare
More informationLevosert levonorgestrel 20mcg/24hour intrauterine device
Levosert levonorgestrel 20mcg/24hour intrauterine device Verdict: Formulary inclusion: Formulary category: Restrictions: Reason for inclusion: Link to formulary: Link to medicine review summary: Levosert
More informationWorld Health Organization Medical Eligibility for Contraceptive Use. Connie Kraus, PharmD, BCACP Professor (CHS) Director Office of Global Health
World Health Organization Medical Eligibility for Contraceptive Use Connie Kraus, PharmD, BCACP Professor (CHS) Director Office of Global Health Objectives After this session, learners should be able to:
More informationAbnormal Uterine Bleeding Case Studies
Case Study 1 Abnormal Uterine Bleeding Case Studies Abigail, a 24 year old female, presents to your office complaining that her menstrual cycles have become a problem. They are now lasting 6 7 days instead
More informationUKMEC SUMMARY TABLE HORMONAL AND INTRAUTERINE CONTRACEPTION
SUMMARY TABLE SUMMARY TABLE HORMONAL AND INTRAUTERINE CONTRACEPTION Cu-IUD = Copper-bearing intrauterine device; LNG-IUS = Levonorgestrel-releasing intrauterine system; IMP = Progestogen-only implant;
More informationReview of IUCD Complications: Lessons from CAT. Dr FG Mhlanga CAT Meeting 24 September 2016
Review of IUCD Complications: Lessons from CAT Dr FG Mhlanga CAT Meeting 24 September 2016 INTRODUCTION The intrauterine device (IUD) is a reliable long term reversible, cost-effective,easy to use and
More informationContraception Update: what s new in 2016? Felicity Young MA BSc (Hons) RMN RGN RM NDFSRH A08 Consultant Nurse for Sexual and Reproductive Healthcare
Contraception Update: what s new in 2016? Felicity Young MA BSc (Hons) RMN RGN RM NDFSRH A08 Consultant Nurse for Sexual and Reproductive Healthcare Declaration of Competing Interests I have not received
More informationHormonal Contraception: Asian View. Hormonal Contraception: Asian View: focused on Chinese View. Prof.Dr.Xiangyan Ruan, MD.PhD
Asian View Prof.Dr.Xiangyan Ruan, MD.PhD Beijing Obstetrics & Gynecology Hospital, Capital Medical University (China) WHO Collaborative Centre - Director of Dept. of Gynecological Endocrinology & & - Fertility
More information100% Highly effective No cost No side effects
effective? Advantages Disadvantages How do I get Cost Abstinence For some it can mean no sexual contact. For others it is no sexual intercourse or vaginal penetration. A permanent surgical procedure available
More informationComplex Medical Problems? Complex Contraception. Objectives 4/17/2015. Sari Kives, MD,FRCSC ; Alene Toulany, MD, FRCPC
Complex Medical Problems? Complex Contraception Sari Kives, MD,FRCSC ; Alene Toulany, MD, FRCPC Objectives Identify contraceptive options for an adolescent with Thrombophelia Diabetes SLE Migraines Epilepsy
More informationCLINICAL PEARLS IN CONTRACEPTION
CLINICAL PEARLS IN CONTRACEPTION Laura Borgelt, PharmD, FCCP, BCPS Associate Professor University of Colorado Denver PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as
More informationWHAT ARE CONTRACEPTIVES?
CONTRACEPTION WHAT ARE CONTRACEPTIVES? Methods used to prevent fertilization *Also referred to as birth control methods With contraceptives, it is important to look at what works for you and your body.
More informationAdolescent Hot Topics: Contraception
Adolescent Hot Topics: Contraception Dr. Stephanie Addison Holt Adolescent Medicine Objectives Discuss way to counsel the sexually active adolescent Explore the latest recommendations and updates regarding
More informationTopic 24: Estrogens and Female Reproductive Drugs
Topic 24: Estrogens and Female Reproductive Drugs I. Contraceptives A. Estrogen-Progestin Contraceptives Note all of these drugs contain one estrogen (listed first) and one progestin Drug to know: ethinyl
More informationBreast Cancer Risk in Patients Using Hormonal Contraception
Breast Cancer Risk in Patients Using Hormonal Contraception Bradley L. Smith, Pharm.D. Smith.bradley1@mayo.edu Pharmacy Ground Rounds Mayo Clinic Rochester April 3 rd, 2018 2017 MFMER slide-1 Presentation
More informationU.S. Medical Eligibility Criteria for Contraceptive Use, 2010
U.S. Medical Eligibility Criteria for Contraceptive Use, 2010 Division of Reproductive Health Centers for Disease Control and Prevention August 1, 2013 National Center for Chronic Disease Prevention and
More informationInformation for Informed Consent for Insertion of a Mirena IUD
Information for Informed Consent for Insertion of a Mirena IUD What is an IUD (intrauterine Device)? An intrauterine device (IUD) is a plastic device that is placed into your uterus to prevent pregnancy.
More informationFamily Planning د. نجمه محمود كلية الطب جامعة بغداد فرع النسائية والتوليد
Family Planning د. نجمه محمود كلية الطب جامعة بغداد فرع النسائية والتوليد Objectives:- To know the different types of contraception To know the failure rate & mechansim of action of each type To explain
More informationReproductive health research at WHO
Reproductive health research at WHO Paul F.A. Van Look, MD PhD Department of Reproductive Health and Research World Health Organization Geneva, 11 March 2004 PVL_GE_StudCourse_MAR04/1 Health is a state
More informationUse of hormonal therapy in acne
Acne Guidelines Use of hormonal therapy in acne Julie C Harper MD Conflict of Interest Disclosure Speaker/Advisor Allergan Bayer Galderma Valeant Investigator Bayer Our task: What is the effectiveness
More informationLearning objectives. Some fun facts. Presenter Disclosure Information. Become familiar with the newest contraceptive options available
8:45 9:30 am Advances and Options in Female Contraception SPEAKER Pelin Batur, MD, FACP, NCMP, CCD Presenter Disclosure Information The following relationships exist related to this presentation: Pelin
More informationBirth Control Options Chart
Hormonal Methods Birth control pills also known as mini-pills 91-99% A daily pill containing hormones that stops you from ovulating. There are combination estrogen or progestin-only (mini-pill) options.
More informationFertility control: what do women want?
FIAPAC 2018 Fertility control: what do women want? Dr. Raymond H.W. Li MBBS, MMedSC, FRCOG, FHKAM (O&G) Cert RCOG/HKCOG (Reprod Med) Department of O&G, The University of Hong Kong The Family Planning Association
More informationThrombosis and Women s Health Risk factors, contraceptive pill, HRT and your doctor
Thrombosis and Women s Health Risk factors, contraceptive pill, HRT and your doctor Dr Matthew Fay GP Principal The Willows Medical Practice- Queensbury GPwSI and Co-Founder Westcliffe Cardiology Service
More informationlevonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer
levonorgestrel 13.5mg intrauterine delivery system (Jaydess ) SMC No. (1036/15) Bayer 6 March 2015 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and advises
More informationLong Acting Reversible Contraception (LARC): Changing the Health of Adolescent Girls Here and Abroad
Long Acting Reversible Contraception (LARC): Changing the Health of Adolescent Girls Here and Abroad Judy Simms-Cendan, MD University of Central Florida College of Medicine History of the IUD Worldwide,
More informationExamining Long-Acting Reversible Contraceptive Methods
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/examining-long-acting-reversible-contraceptivemethods/7078/
More informationNotes to Teacher continued Contraceptive Considerations
Abstinence a conscious decision to refrain from sexual intercourse 100% pregnancy will not occur if close contact between the penis and vagina does not take place. The risk of a number of STDs, including
More informationCan you imagine reversible birth control that s more than 99% effective and 100% hormone free, too?
Can you imagine reversible birth control that s more than 99% effective and 100% hormone free, too? BIRTH CONTROL THAT FITS YOUR LIFE, NATURALLY. ParaGard is a registered trademark of Teva Women s Health,
More informationContraception in Adolescents and Young Adults with a Chronic Illness
Contraception in Adolescents and Young Adults with a Chronic Illness Lawrence S. Neinstein M.D. Professor of Pediatrics and Medicine Chief, Division of College Health USC Keck School of Medicine Executive
More information2
1 2 3 1. Usinger KM et al. Intrauterine contraception continuation in adolescents and young women: a systematic review. J Pediatr Adolesc Gynecol 2016; 29: 659 67. 2. Kost K et al. Estimates of contraceptive
More informationCODING GUIDELINES FOR CONTRACEPTIVES. Effective June 1, 2017 Version 1.40
CODING GUIDELINES FOR CONTRACEPTIVES Effective June 1, 2017 Version 1.40 TABLE OF CONTENTS ICD-10 CM Diagnosis Codes: Encounter for Contraception page 2 Coding for IUD Insertion and Removal Procedures
More informationLearning objectives. Some fun facts. Presenter Disclosure Information. Discuss the newest contraceptive options available
2:15 3pm Advances and Options in Female Contraception SPEAKER Pelin Batur, MD, FACP, NCMP, CCD Presenter Disclosure Information The following relationships exist related to this presentation: Pelin Batur,
More informationCue Cards for Counseling Adolescents on Contraception
Cue Cards for Counseling Adolescents on Contraception About the Cue Cards This set of contraceptive counseling cue cards was developed to support a range of providers (such as facility-based providers,
More informationBirth Control- an Overview. Keith Merritt, MD. Remember, all methods of birth control are safer and have fewer side effects than pregnancy
Birth Control- an Overview Keith Merritt, MD Basics Remember, all methods of birth control are safer and have fewer side effects than pregnancy Even with perfect use, each method of birth control has a
More informationBirth Control in Patients with Congenital Heart Disease
Birth Control in Patients with Congenital Heart Disease Arwa Saidi MB. BCh. MEd. FACC University of Florida Departments of Pediatrics and Internal Medicine Gainesville, FL There are an increasing number
More informationContraception IUS and Intradermal Implant
Contraception IUS and Intradermal Implant David Glenn Weismiller, MD, ScM, FAAFP Department of Family and Community Medicine University of Nevada, Las Vegas School of Medicine Disclosure Statement I have
More informationContraception for young people. Dr Cindy Farmer Bristol Sexual Health Services Fri 8 th May 2015
Contraception for young people Dr Cindy Farmer Bristol Sexual Health Services Fri 8 th May 2015 Learning objectives Be able to apply the principles of confidentiality, Fraser Guidelines, consent and safeguarding
More informationthe IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD the IUD your guide to
your guide to Helping you choose the method of contraception that s best for you IUD IUD the e IUD IU IUD the IUD 2 3 The intrauterine device (IUD) An IUD is a small plastic and copper device that s put
More informationSimplifying Vide Contraception. University of Utah Department of Ob/Gyn Post Grad Course February 13, 2017 David Turok
Simplifying Vide Contraception University of Utah Department of Ob/Gyn Post Grad Course February 13, 2017 David Turok Background Objectives At the conclusion of this presentation participants will be able
More informationChapter 7 Infertility, Contraception, and Abortion
Chapter 7 Infertility, Contraception, and Abortion Infertility Incidence Affects about 10% to 15% of reproductive-age population Subfertility: prolonged time to conceive Sterility: inability to conceive
More informationTrudy Bush Lecture: Using Progestins in Clinical Practice. Progestins in Clinical Practice: Outline. NAMS Definitions. FDA Approved Oral Progestins
1 Women's Health 2015: The 23rd Annual Congress FRIDAY, April 17, 2015 Trudy Bush Lecture: Using Progestins in Clinical Practice Commercial Disclosure: I am a consultant on litigation relating to the Mirena
More informationHormonal Treatment of Acne and Hirsutism. Julie C Harper MD
Hormonal Treatment of Acne and Hirsutism Julie C Harper MD none Conflict of Interest Androgen blockade Decrease androgen production by the gonads or adrenal gland Decrease circulating free testosterone
More informationThe use of long-acting reversible contraceptive
Overcoming LARC complications: 7 case challenges The strings to your patient s intrauterine device (IUD) are missing. Clinical experience and ACOG direction guide the management plans for this and more
More informationFamily Planning UNMET NEED. The Nurse Mildred Radio Talk Shows
Family Planning UNMET NEED The Nurse Mildred Radio Talk Shows TOPIC 9: IUD/COIL Guests FP counsellor from MSU, RHU& UHMG Nurse Mildred Nurse Betty Objectives of the programme: To inform listeners about
More informationMenstrual Disorders & Ambulatory Gynaecology
Menstrual Disorders & Ambulatory Gynaecology Mr. Nagui Lewis Aziz M B, CH B, FRCOG Consultant Gynaecologist The Royal Oldham Hospital 01/09/2018 Heavy menstrual bleeding (HMB ) is a common problem responsible
More informationChapter 100 Gynecologic Disorders
Chapter 100 Gynecologic Disorders Episode Overview: 1. Describe the presentation and RF for Adnexal torsion 2. List the imaging findings of adnexal torsion (US vs CT) 3. What is the management of adnexal
More informationLearning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories
Learning Objectives Identify common symptoms of the menopause transition Understand the risks and benefits of hormone replacement therapy (HRT) Be able to choose an appropriate hormone replacement regimen
More informationWORTH A CLOSER LOOK.
A birth control pill... WORTH A CLOSER LOOK. Ask your healthcare provider about. Please see Important Safety Information including Boxed Warning throughout this brochure and on pages 4 and 5. offers a
More information